NO20003960L - Salter av paroxsetine - Google Patents
Salter av paroxsetineInfo
- Publication number
- NO20003960L NO20003960L NO20003960A NO20003960A NO20003960L NO 20003960 L NO20003960 L NO 20003960L NO 20003960 A NO20003960 A NO 20003960A NO 20003960 A NO20003960 A NO 20003960A NO 20003960 L NO20003960 L NO 20003960L
- Authority
- NO
- Norway
- Prior art keywords
- paroxsetine
- salts
- hypophosphoric
- methylbenzenesulfonic
- paroxetine
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4525—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Neurology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Salt av paroxetine med en syre valgt fra gruppen bestående av svovelsyre, vinsyre, oksalsyre, fumarsyre, propionsyre, maursyre, glutaminsyre, ravsyre, benzosyre, sitronsyre, salpetersyre, fosforsyre, 4-metylbenzensulfonsyre, hypofosforsyrling, melkesyre og mandelsyrer og glycin er nyttige ved behandling og forebygging av visse CNS-lidelser.
Applications Claiming Priority (34)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9802644.6A GB9802644D0 (en) | 1998-02-06 | 1998-02-06 | Novel compounds |
GBGB9802657.8A GB9802657D0 (en) | 1998-02-06 | 1998-02-06 | Novel compounds |
GBGB9802664.4A GB9802664D0 (en) | 1998-02-06 | 1998-02-06 | Novel compounds |
GBGB9802665.1A GB9802665D0 (en) | 1998-02-06 | 1998-02-06 | Novel compounds |
GBGB9802653.7A GB9802653D0 (en) | 1998-02-06 | 1998-02-06 | Novel compounds |
GBGB9802654.5A GB9802654D0 (en) | 1998-02-06 | 1998-02-06 | Novel compounds |
GBGB9802698.2A GB9802698D0 (en) | 1998-02-06 | 1998-02-06 | Novel compounds |
GBGB9802645.3A GB9802645D0 (en) | 1998-02-06 | 1998-02-06 | Novel compounds |
GBGB9802646.1A GB9802646D0 (en) | 1998-02-06 | 1998-02-06 | Novel compounds |
GBGB9802640.4A GB9802640D0 (en) | 1998-02-06 | 1998-02-06 | Novel compounds |
GBGB9802639.6A GB9802639D0 (en) | 1998-02-06 | 1998-02-06 | Novel compounds |
GBGB9802656.0A GB9802656D0 (en) | 1998-02-06 | 1998-02-06 | Novel compounds |
GBGB9802659.4A GB9802659D0 (en) | 1998-02-06 | 1998-02-06 | Novel compounds |
GBGB9802661.0A GB9802661D0 (en) | 1998-02-06 | 1998-02-06 | Novel compounds |
GBGB9802655.2A GB9802655D0 (en) | 1998-02-06 | 1998-02-06 | Novel compounds |
GBGB9802658.6A GB9802658D0 (en) | 1998-02-06 | 1998-02-06 | Novel compounds |
GBGB9802638.8A GB9802638D0 (en) | 1998-02-06 | 1998-02-06 | Novel compounds |
GBGB9817340.4A GB9817340D0 (en) | 1998-08-08 | 1998-08-08 | Novel compounds |
GBGB9817364.4A GB9817364D0 (en) | 1998-08-08 | 1998-08-08 | Novel compounds |
GBGB9817307.3A GB9817307D0 (en) | 1998-08-08 | 1998-08-08 | Novel compound |
GBGB9817309.9A GB9817309D0 (en) | 1998-08-08 | 1998-08-08 | Novel compounds |
GBGB9817321.4A GB9817321D0 (en) | 1998-08-08 | 1998-08-08 | Novel compound |
GBGB9817360.2A GB9817360D0 (en) | 1998-08-08 | 1998-08-08 | Novel compounds |
GBGB9817317.2A GB9817317D0 (en) | 1998-08-08 | 1998-08-08 | Novel compounds |
GBGB9817344.6A GB9817344D0 (en) | 1998-08-08 | 1998-08-08 | Novel compounds |
GBGB9817359.4A GB9817359D0 (en) | 1998-08-08 | 1998-08-08 | Novel compounds |
GBGB9817322.2A GB9817322D0 (en) | 1998-08-10 | 1998-08-10 | Novel compounds |
GBGB9817320.6A GB9817320D0 (en) | 1998-08-10 | 1998-08-10 | Novel compounds |
GBGB9826172.0A GB9826172D0 (en) | 1998-11-30 | 1998-11-30 | Novel compound |
GBGB9826173.8A GB9826173D0 (en) | 1998-11-30 | 1998-11-30 | Novel compounds |
GBGB9827277.6A GB9827277D0 (en) | 1998-12-11 | 1998-12-11 | Novel compound |
GBGB9827341.0A GB9827341D0 (en) | 1998-12-11 | 1998-12-11 | Novel compounds |
GBGB9828775.8A GB9828775D0 (en) | 1998-12-29 | 1998-12-29 | Novel compounds |
PCT/GB1999/000380 WO1999040084A1 (en) | 1998-02-06 | 1999-02-05 | Salts of paroxetine |
Publications (2)
Publication Number | Publication Date |
---|---|
NO20003960D0 NO20003960D0 (no) | 2000-08-04 |
NO20003960L true NO20003960L (no) | 2000-09-25 |
Family
ID=27586915
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20003960A NO20003960L (no) | 1998-02-06 | 2000-08-04 | Salter av paroxsetine |
Country Status (11)
Country | Link |
---|---|
EP (1) | EP1053234A1 (no) |
JP (1) | JP2002505254A (no) |
KR (1) | KR20010040711A (no) |
BG (1) | BG104737A (no) |
CA (1) | CA2319652A1 (no) |
EA (1) | EA200000815A1 (no) |
IL (1) | IL137684A0 (no) |
NO (1) | NO20003960L (no) |
PL (1) | PL342295A1 (no) |
SK (1) | SK11812000A3 (no) |
WO (1) | WO1999040084A1 (no) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CH689805A8 (fr) * | 1998-07-02 | 2000-02-29 | Smithkline Beecham Plc | Méthanesulfonate de paroxétine, procédé pour sa préparation et compositions pharmaceutiques le contenant. |
GB9814316D0 (en) * | 1998-07-02 | 1998-09-02 | Smithkline Beecham Plc | Novel compounds |
WO2000008016A1 (en) * | 1998-08-08 | 2000-02-17 | Smithkline Beecham Plc | Paroxetine salts |
GB9827431D0 (en) * | 1998-12-11 | 1999-02-03 | Smithkline Beecham Plc | Novel compound |
AU5078700A (en) * | 1999-06-22 | 2001-01-09 | Smithkline Beecham Plc | Novel composition |
HU226912B1 (en) * | 2000-04-07 | 2010-03-01 | Richter Gedeon Nyrt | New paroxetin salt and medicament containing it |
HUP0302528A2 (hu) * | 2001-01-05 | 2003-11-28 | Eli Lilly And Co. | Ingerlő aminosav receptor antagonisták és e vegyületeket tartalmazó gyógyászati készítmények és eljárás a vegyületek előállítására |
US20040225128A1 (en) * | 2001-08-02 | 2004-11-11 | Callewaert George Leo | Paroxetine isethionate salt, process of preparation and use in the treatment of depression |
KR100672184B1 (ko) | 2004-09-21 | 2007-01-19 | 주식회사종근당 | 파록세틴의 콜린산 또는 콜린산 유도체 염 |
CN108218844B (zh) * | 2018-03-08 | 2021-01-19 | 合肥科大生物技术有限公司 | 一种美金刚帕罗西汀共晶盐及其制备方法、药物组合物、应用 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8430581D0 (en) * | 1984-12-04 | 1985-01-09 | Ferrosan As | Treatment |
DE3688827T2 (de) * | 1985-10-25 | 1994-03-31 | Beecham Group Plc | Piperidinderivat, seine Herstellung und seine Verwendung als Arzneimittel. |
CA2206592A1 (en) * | 1996-05-30 | 1997-11-30 | Shu-Zhong Wang | Method of producing amorphous paroxetine hydrochloride |
HU221921B1 (hu) * | 1996-07-08 | 2003-02-28 | Richter Gedeon Vegyészeti Gyár Rt. | N-benzil-piperidin- és tetrahidropiridinszármazékok és eljárás azok előállítására |
-
1999
- 1999-02-05 KR KR1020007008591A patent/KR20010040711A/ko not_active Application Discontinuation
- 1999-02-05 WO PCT/GB1999/000380 patent/WO1999040084A1/en not_active Application Discontinuation
- 1999-02-05 SK SK1181-2000A patent/SK11812000A3/sk unknown
- 1999-02-05 JP JP2000530513A patent/JP2002505254A/ja active Pending
- 1999-02-05 PL PL99342295A patent/PL342295A1/xx not_active Application Discontinuation
- 1999-02-05 EA EA200000815A patent/EA200000815A1/ru unknown
- 1999-02-05 IL IL13768499A patent/IL137684A0/xx unknown
- 1999-02-05 CA CA002319652A patent/CA2319652A1/en not_active Abandoned
- 1999-02-05 EP EP99904971A patent/EP1053234A1/en not_active Withdrawn
-
2000
- 2000-08-04 NO NO20003960A patent/NO20003960L/no not_active Application Discontinuation
- 2000-08-30 BG BG104737A patent/BG104737A/xx unknown
Also Published As
Publication number | Publication date |
---|---|
CA2319652A1 (en) | 1999-08-12 |
EA200000815A1 (ru) | 2001-02-26 |
EP1053234A1 (en) | 2000-11-22 |
KR20010040711A (ko) | 2001-05-15 |
SK11812000A3 (sk) | 2001-08-06 |
PL342295A1 (en) | 2001-06-04 |
BG104737A (en) | 2001-07-31 |
NO20003960D0 (no) | 2000-08-04 |
WO1999040084A1 (en) | 1999-08-12 |
IL137684A0 (en) | 2001-10-31 |
JP2002505254A (ja) | 2002-02-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20003960L (no) | Salter av paroxsetine | |
MXPA03006248A (es) | Derivados de acido fumarico como inhibidores de nf-kappab. | |
ZA997407B (en) | Process for the fermentative production of D-pantothenic acid using coryneform bacteria. | |
DE69507199T2 (de) | Heterocyclylcarbonylsubstituierte Benzofuranyl- und -thiophenylalkancarbonsäurederivate | |
IL147184A0 (en) | Substituted benzimidazole | |
EP1163910A4 (en) | PROPHYLAXIS / REMEDIES FOR INTERSTITIAL PNEUMONIA AND PULMONARY FIBROSIS | |
ZA200005217B (en) | α-sulfonylamino hydroxamic acid inhibitors of matrix metalloproteinases for the treatment of peripheral or central nervous system disorders. | |
NO20000093D0 (no) | (+)-Norcisaprid nyttig for 5-HT3 og 5-HT4-medierte forstyrrelser | |
DK1236728T3 (da) | S-type 2-substituerede hydroxy-2-indolidinylsmörsyreesterforbindelser og fremgangsmåde til fremstilling deraf | |
WO2003006443A3 (de) | 2-`4-(naphtalin-2yl)-thiazol-2-ylaminocarbonyl benzoesäure und 2-`4-(naphtalin-2yl)-pyrimidin-2-ylaminocarbonyl benzoesäure und andere verbindungen als telomerase-hemmer zur anwendung in der tumortherapie | |
ZA200108917B (en) | Process for the preparation of carboxylic acid salts from primary alcohols. | |
IL157495A0 (en) | Method for the production of d-panthothenic acid and/or salts thereof as adjunct for animal feedstuffs | |
NO881997D0 (no) | Nye 4-benzyl-1-(2h)-ftalazinonderivater med en aminosyrerest. | |
PL346656A1 (en) | Process for the production of a naphthyridine carboxylic acid derivative (methanesulfonate sesquihydrate) | |
NO912475D0 (no) | Tiazolidinkarboksylsyreamidderivater med antiallergisk aktivitet, og fremgangsmaate til fremstilling derav. | |
MXPA02002355A (es) | Procedimiento para la produccion de derivados de acido naftiridin-3-carboxilico. | |
MY126789A (en) | Intermediates for the production of quinoline carboxylic acid derivatives | |
HK1042705A1 (en) | Crystal modification B of 8-cyano-1-cyclopropyl-7-(1S,6S-2,8-diazabicyclo (4.3.0)nonan-8-yl)-6-fluoro-1,4-dihydro-4-oxo-3-quinoline carboxylic acid. | |
HK1047433A1 (zh) | 環狀乳酸齊聚物的製備方法 | |
HK1047279A1 (zh) | 環狀乳酸齊聚物的製備方法 | |
HK1042704A1 (en) | Semi-hydrochloride of 8-cyan-1-cyclopropyl-7-(1S,6S-2,8-diazabicyclo Ä4.3.0Ünonan-8-yl)-6-fluoro-1,4-dihydro -4-oxo-3- quinoline carboxylic acid. | |
PL373247A1 (en) | Method for treating tumors by the administration of tegafur, uracil, folinic acid, and cyclophosphamide | |
ES2147499A1 (es) | Derivados de acidos carboxilicos, metodo para su elaboracion y agentes terapeuticos que contienen estos compuestos. | |
NO20044629L (no) | Fremgangsmate til fremstilling av sure salter av gemifloksasin. | |
WO2002066666A3 (de) | Verfahren zur herstellung von d-pantothensäure und/oder deren salze als zusatz zu tierfuttermitteln |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |